Answers are grounded in this paper and cite their sources.
Network meta-analysis assesses individual glucose-lowering drugs' effects on dementia risk, highlighting GLP-1 agonists.
To assess the effects of individual glucose-lowering drugs on the risk of all-cause dementia, with emphasis on drug-level distinctions within the GLP-1 receptor agonist class.
No takes yet. Share an insight, caveat, or question.
Sharma et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: